There's no shortage of hype and excitement surrounding Viking Therapeutics (NASDAQ: VKTX) stock these days. The company has a promising weight loss drug candidate in its pipeline at a time when many healthcare businesses are eager to get a piece of that massive market. This year alone, shares of Viking are already up a staggering 240%, and that's even after they've given back some gains from their peak.

Yet its market cap still isn't all that high at less than $7 billion. Given the hope around the business and the possibility for it to get much bigger and more valuable in the future, is this a stock that has the potential to make you a millionaire?

Viking doesn't have any approved products or any consistent sources of revenue right now, which makes it a risky investment. But investors have become more bullish about the company of late due to recently revealed trial results for VK2735, a GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that can assist patients with weight loss.

Continue reading

Source Fool.com